Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003463072 | SCV004198843 | uncertain significance | Familial adenomatous polyposis 2 | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003463072 | SCV004677280 | uncertain significance | Familial adenomatous polyposis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 146 of the MUTYH protein (p.Ile146Met). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |